Recovery Act Funds Expand Studies Of Stem Cell Biology
The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.
[Read the full article here]Related News:
Coriell Receives $27M for Human Genetics Biobank, New Stem Cell Lab
Coriell Institute Receives $27M for Human Genetics Biobank and New Stem Cell Laboratory
Australian First For Melbourne Stem Cell Scientists